Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.75
Bid: 18.00
Ask: 19.50
Change: 0.25 (1.35%)
Spread: 1.50 (8.333%)
Open: 18.50
High: 19.50
Low: 17.75
Prev. Close: 18.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg cuts Anglo American and Gem Diamonds

Thu, 06th Oct 2022 10:46

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Bank of America raises Admiral Group price target to 2,000 (1,960) pence - 'underperform'

----------

Bank of America cuts Prudential price target to 1,360 (1,455) pence - 'buy'

----------

Bank of America cuts Aviva price target to 480 (500) pence - 'neutral'

----------

Bank of America cuts Hargreaves Lansdown price target to 1,050 (1,100) pence - 'buy'

----------

Bank of America cuts M&G price target to 222 (245) pence - 'buy'

----------

Deutsche Bank cuts M&G price target to 200 (230) pence - 'hold'

----------

Bank of America cuts Phoenix Group price target to 725 (800) pence - 'buy'

----------

HSBC raises Legal & General price target to 350 (335) pence - 'buy'

----------

Bank of America cuts Legal & General price target to 280 (315) pence - 'buy'

----------

Deutsche Bank cuts St James's Place target to 1,370 (1,420) pence - 'buy'

----------

Bank of America cuts St James's Place price target to 1,300 (1,435) pence - 'neutral'

----------

RBC raises Segro to 'outperform' (sector perform) - price target 900 (1,075) pence

----------

RBC cuts British Land price target to 330 (375) pence - 'sector perform'

----------

RBC cuts Land Securities price target to 550 (650) pence - 'sector perform'

----------

Goldman Sachs raises Standard Chartered price target to 890 (870) pence - 'buy'

----------

Goldman Sachs raises HSBC price target to 750 (705) pence - 'neutral'

----------

UBS cuts Intertek price target to 6,000 (6,500) pence - 'buy'

----------

UBS cuts RS Group price target to 1,300 (1,375) pence - 'buy'

----------

UBS cuts Experian price target to 3,200 (3,400) pence - 'buy'

----------

Goldman Sachs cuts Auto Trader Group price target to 621 (625) pence - 'neutral'

----------

HSBC cuts Auto Trader Group price target to 740 (795) pence - 'buy'

----------

Goldman Sachs cuts Tesco price target to 245 (255) pence - 'buy'

----------

Credit Suisse cuts Tesco price target to 238 (292) pence - 'neutral'

----------

Credit Suisse cuts Sainsbury price target to 184 (231) pence - 'underperform'

----------

Goldman Sachs cuts Next price target to 5,750 (7,600) pence - 'neutral'

----------

RBC raises Burberry price target to 1,800 (1,700) pence - 'sector perform'

----------

Goldman Sachs raises Burberry price target to 2,490 (2,410) pence - 'buy'

----------

Exane BNP starts Entain with 'outperform' - price target 13,500 pence

----------

Exane BNP starts Flutter with 'outperform' - price target 12,500 pence

----------

Deutsche Bank cuts Reckitt price target to 6,900 (7,200) pence - 'buy'

----------

Berenberg cuts Anglo American to 'hold' (buy) - price target 3,000 (3,200) pence

----------

Berenberg cuts Endeavour Mining price target to 2,900 (3,000) pence - 'buy'

----------

Berenberg raises Fresnillo price target to 800 (700) pence - 'hold'

----------

Berenberg cuts Rio Tinto price target to 4,000 (4,300) pence - 'sell

----------

FTSE 250

----------

Berenberg cuts Sirius Real Estate price target to 123 (150) pence - 'buy'

----------

RBC cuts Great Portland price target to 470 (485) pence - 'underperform'

----------

RBC cuts Workspace Group price target to 600 (675) pence - 'outperform'

----------

RBC cuts Derwent London price target to 2,000 (2,100) pence - 'underperform'

----------

RBC cuts Hammerson price target to 15.5 (16.5) pence - 'underperform'

----------

RBC cuts Big Yellow Group price target to 1,100 (1,200) pence - 'underperform'

----------

RBC cuts Warehouse REIT price target to 115 (120) pence - 'underperform'

----------

RBC cuts Tritax Eurobox price target to 90 (105) pence - 'outperform'

----------

RBC cuts Tritax Big Box price target to 190 (205) pence - 'outperform'

----------

RBC cuts LondonMetric Property price target to 245 (270) pence - 'outperform'

----------

Barclays cuts Computacenter price target to 2,385 (2,900) pence - 'equal weight'

----------

Barclays cuts Babcock International target to 325 (358) pence - 'equal weight'

----------

Jefferies cuts Spire Healthcare price target to 240 (251) pence - 'hold'

----------

Jefferies cuts Johnson Matthey price target to 2,300 (2,400) pence - 'buy'

----------

Numis cuts Synthomer to 'hold' ('add') - target 120 (230) pence

----------

Berenberg raises Centamin price target to 114 (112) pence - 'buy'

----------

UBS cuts Serco price target to 190 (210) pence - 'buy'

----------

Barclays cuts Renishaw price target to 3,520 (3,975) pence - 'underweight'

----------

Berenberg cuts John Wood price target to 180 (270) pence - 'buy'

----------

UBS cuts Hays price target to 160 (220) pence - 'buy'

----------

Bank of America cuts Quilter price target to 104 (115) pence - 'underperform'

----------

Bank of America cuts Direct Line price target to 185 (195) pence - 'underperform'

----------

JPMorgan cuts Close Brothers price target to 1,240 (1,370) pence - 'neutral'

----------

Bank of America cuts Ninety One price target to 215 (220) pence - 'neutral'

----------

Bank of America raises Man Group price target to 305 (300) pence - 'buy'

----------

Bank of America cuts Jupiter Fund price target to 85 (115) pence - 'underperform'

----------

Bank of America cuts Ashmore Group price target to 175 (185) pence - 'underperform'

----------

Deutsche Bank cuts abrdn price target to 125 (135) pence - 'sell'

----------

Credit Suisse cuts Moneysupermarket target to 202 (208) pence - 'neutral'

----------

SMALL CAP

----------

UBS cuts Just Eat Takeaway price target to 2,200 (2,400) pence - 'buy'

----------

Berenberg raises Yellow Cake price target to 600 (500) pence - 'buy'

----------

Berenberg raises Yamana Gold price target to 660 (640) pence - 'buy'

----------

Berenberg cuts Resolute Mining price target to 48 (49) pence - 'buy'

----------

Berenberg cuts Tharisa price target to 250 (270) pence - 'buy'

----------

Berenberg raises Sovereign Metals price target to 84 (75) pence - 'buy'

----------

Berenberg cuts Jubilee Metals price target to 19 (20) pence - 'buy'

----------

Berenberg cuts Hochschild Mining price target to 90 (100) pence - 'hold'

----------

Berenberg cuts Griffin Mining price target to 140 (160) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 280 (300) pence - 'buy'

----------

Berenberg raises BHP Group price target to 2,300 (2,100) pence - 'hold'

----------

Berenberg cuts Atalaya Mining price target to 310 (370) pence - 'buy'

----------

Berenberg cuts Anglo Pacific Group price target to 330 (390) pence - 'buy'

----------

Berenberg raises Petra Diamonds to 'buy' (hold) - price target 200 (130) pence

----------

Berenberg cuts Gem Diamonds to 'hold' (buy) - price target 40 (60) pence

----------

RBC raises Empiric Student Property target to 90 (84) pence - 'sector perform'

----------

Jefferies cuts Angle price target to 170 (200) pence - 'buy'

----------

Bank of America cuts Old Mutual price target to 68.50 (76) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
21 Jun 2019 15:26

Angle upbeat on recent cancer research results

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the University Medical Centre Hamburg-Eppendorf (UKE) cancer centre has published results of work demonstrating that its 'Parsortix' system can be used as a liquid biopsy to investigate programmed death-ligand 1 (PD-L1) status in non small cell lung cancer (NSCLC) patients.

Read more
21 Jun 2019 12:56

Angle's Parsortix Successfully Investigates Immunotherapy Target

(Alliance News) - Angle PLC on Friday said its Parsortix system has been successfully used as a liquid biopsy to investigate an immunotherapy target in lung cancer.Shares in Angle were up a

Read more
5 Jun 2019 13:04

Angle's Parsortix And HyCEAD Ziplex Systems Identify Cancer In Study

LONDON (Alliance News) - Angle PLC on Wednesday announced positive results from a study evaluating the ability of its Parsortix and HyCEAD Ziplex platforms to test for ovarian cancer.The to

Read more
31 May 2019 09:53

Angle reveals positive results from latest Parsortix study

(Sharecast News) - Liquid biopsy company Angle announced positive results from its 'Parsortix' FDA clinical study for metastatic breast cancer on Friday.

Read more
26 Apr 2019 12:48

Angle's Parsortix system used in more groundbreaking research

(Sharecast News) - Liquid biopsy company Angle announced on Friday that its 'Parsortix' system has been utilised in further groundbreaking new cancer research, demonstrating the role of myeloid-derived suppressor cells (MDSCs) as part of large circulating tumor cell (CTC) clusters, which are 50x more likely to generate metastasis than single CTCs, for the first time.

Read more
26 Apr 2019 12:29

Angle's Parsortix System Used In Further "Groundbreaking" Research

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said its Parsortix system has been used in "groundbreaking" cancer research.The research showed the first the time

Read more
18 Apr 2019 11:35

US Cancer Centre Uses Angle's Parsortix System For Assessments

LONDON (Alliance News) - Angle PLC on Thursday said its ParsortixTM system was used by the University of Texas MD Anderson Cancer Center to develop a new technique for assessing the metastatic of

Read more
12 Apr 2019 15:25

Angle's Parsortix to be used in new Greece study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that a leading customer has established a multi-centre study to investigate biomarkers on circulating tumor cells (CTCs), using its 'Parsortix' system, which could give advance warning of relapse in non small cell lung cancer (NSCLC).

Read more
12 Apr 2019 11:59

University Of Athens Cancer Study To Use Angle's Parsortix System

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said a "leading" customer has set up a multi-centre study using its Parsortix system.The study is being carried out

Read more
7 Mar 2019 13:09

Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix

LONDON (Alliance News) - Angle PLC on Thursday said it has completed enrolment for a US study of its Parsortix biopsy technology in metastatic breast cancer.All of the 400 subjects required

Read more
7 Mar 2019 09:35

Angle completes enrolment in Parsortix breast cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cancer was now complete.

Read more
28 Feb 2019 13:30

Angle Enrolls First Patients In Ovarian Cancer Study

LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics approval.The study will be divided a a

Read more
25 Feb 2019 10:51

Angle client demonstrates new use for 'Parsortix' system

(Sharecast News) - Liquid biopsy company Angle said on Monday that one of its leading customers, the Disseminated Cancer Cell Network (DCCNet) in Duesseldorf, has published new results in a peer-reviewed journal of work done to harvest circulating tumor cells (CTCs) from diagnostic leukapheresis (DLA) samples.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.